And I will admit, I have an ulterior motive for posting. The following statement caught my eye. Sort of puts a hole in the argument that drug companies are independent of Federal funding for drug research, so we don't need to support research at the federal level (a la stem cells):
Other novel drugs are in development, but NicVax, by Nabi Biopharmaceuticals, a Boca Raton, Fla., biotech company with labs in Rockville, Md., is most advanced among the vaccines.
. . . .
The Food and Drug Administration has granted the vaccine fast-track status, meaning it will get prompt review, and the National Institute on Drug Abuse just gave Nabi a second $4 million grant to finance the study and NicVax's development.